Status:
TERMINATED
Patient and Care Partner Experiences Living With Multiple Myeloma (PaCE-MM)
Lead Sponsor:
UNC Lineberger Comprehensive Cancer Center
Collaborating Sponsors:
National Institute on Aging (NIA)
Conditions:
Multiple Myeloma
Eligibility:
All Genders
55+ years
Brief Summary
This research study is explore the impact over time of multiple myeloma and its associated treatments on the physical and cognitive function and quality of life of patients and their care partners and...
Detailed Description
This study aims to identify the factors, for example, age, race, sex, education, household income, clinical or other geriatric conditions such as depression, anxiety, or lack of social support that ca...
Eligibility Criteria
Inclusion
- Patients must meet the following inclusion criteria to participate in this study:
- Aged ≥55
- New myeloma diagnosis as defined by the International Myeloma Working Group, does not have another non-myeloma plasma cell disorder such as POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal plasma cell disorder, skin changes) or amyloidosis.
- Starting systemic treatment.
- Able to understand and speak in English.
- Able to provide informed consent to participate.
- Care Partners must meet the following inclusion criteria to participate in this study
- Aged ≥18.
- Able to understand and speak in English.
- Able to provide informed consent to participate.
- Be a care partner for a patient with multiple myeloma and is also enrolled in the assessment portion of this study.
- Willing and able to participate in semi-structured interviews.
Exclusion
- All participants meeting any of the following exclusion criteria at enrollment will be excluded from the study: Inability to read and speak English.
- Dementia altered mental status, or any psychiatric condition that would prohibit the understanding or rendering of informed consent.
Key Trial Info
Start Date :
February 8 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 3 2023
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT05276622
Start Date
February 8 2022
End Date
October 3 2023
Last Update
December 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, United States, 27514